News Oligomerix Presents Preclinical Data at TAU2020 Global Conference for Small Molecule Inhibitor of Tau Self-Association February 12, 2020 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix to Present at BIO CEO & Investor Conference, Tau2020 Global ConferenceNext →Oligomerix Announces Appointment of Robert Foerster, Former Pfizer Executive, as Chief Financial Officer
